• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Big tech poised to beat healthcare in reaping value from artificial intelligence, report says

Share:

April 2, 2019

Amid all the promise AI brings, a new report warns that healthcare payers and providers must move quickly to ensure they have the right talent and data to succeed.

Artificial intelligence will expose inefficiencies, improve medical decision-making and increase the quality of care, according to a new report from Boston Consulting Group. But the report also warned that companies in the traditional sectors of healthcare — payers and providers among them — risk ceding much of the value created by AI tools to technology vendors and consumers.

WHY IT MATTERS

With mounting pressure to contain or reduce healthcare costs and improve outcomes, AI is seen as a path to cost savings through greater efficiency — allowing providers to diagnose disease earlier and with more accuracy, for example.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Healthcare professionals could also use AI tools to create individualized treatment plans that support value-based care by reducing risk, improving outcomes and cutting costs.

The report noted that for healthcare providers, AI-driven resource scheduling, coding, and billing would improve operational efficiency, AI would yield major efficiencies in claims handling and other operations for payers, including improved fraud, waste, and abuse detection.

THE BIGGER TREND

A February report by Frost & Sullivan predicts hospitals and diagnostic labs will be among the biggest adopters of digital pathology tools, with AI making a big impact on how and where the digital tools are employed.

Just this week the Centers for Medicare and Medicaid Services announced a three stage competition it hopes will speed the development of AI technologies that can better predict health outcomes and boost quality of care.

The Center for Clinical Artificial Intelligence, created by Cleveland Clinic Enterprise Analytics, recently launched a center for AI development, while Northwestern Medicine is validating algorithms to help more accurately screen for damage to valves with a digital stethoscope.

“AI is to some degree already being deployed across all incumbent sectors of healthcare today and will play an exponentially larger role in the years ahead,” BCG partner Alexander Aboshiha, said in a statement. “Companies need to move quickly to harness this rapidly developing technology — including by ensuring they have access to the right data and the right talent to succeed.”

Meanwhile, players like Google parent company Alphabet, IBM, Apple, Amazon, and Alibaba are making significant investments in developing AI-driven products and solutions including clinical decision support for providers, diagnosis tools for medical technology companies and population health management for payers.

ON THE RECORD

“AI will drive major advances in realizing the vision of value-based health care, Ryan Gallagher, BCG project leader, said in a statement. “It has the potential to detect connections and correlations between medical treatment and patient outcomes in a way that hasn’t been possible before.”

When it comes to remote prevention and care, AI-powered “virtual agents” could be used to conduct an initial consultation with a patient, screen out those who do not need to see a doctor, or provide important information to physicians about those who do need treatment.

In addition, the report noted AI applications in medical imaging and other clinical tests can help doctors identify conditions, while biopharma companies could use AI to leverage past screening results and clinical data to help identify and develop promising drugs.

Date: April 02, 2019

Source: HealthcareITNews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Lexicon Pharmaceuticals Completes the Sale of XERMELO to TerSera TherapeuticsLexicon Pharmaceuticals Completes the Sale of XERMELO to TerSera Therapeutics
  • Startups talk the if, when and how of AI-augmented dashboardsStartups talk the if, when and how of AI-augmented dashboards
  • The Role of Digital Mental Health in the Healthcare JourneyThe Role of Digital Mental Health in the Healthcare Journey
  • HORIBA Acquires MedTest Dx and Pointe Scientific to Expand Laboratory Chemistry OfferingsHORIBA Acquires MedTest Dx and Pointe Scientific to Expand Laboratory Chemistry Offerings
  • Canopy Growth Buys Out Cannabis Research Joint VentureCanopy Growth Buys Out Cannabis Research Joint Venture
  • Most clinical trial participants find benefits of sharing personal data outweigh risksMost clinical trial participants find benefits of sharing personal data outweigh risks
  • First Databank Clinician Addresses COVID19 Vaccine SkepticismFirst Databank Clinician Addresses COVID19 Vaccine Skepticism
  • 6 ways Amazon could disrupt healthcare6 ways Amazon could disrupt healthcare

Trending This Week

  • Pharmaceutical Compliance Software Market 2022 to Showing Impressive Growth By | [no. of Pages: 118] Industry Trends, Share, Size, Top Key Players Analysis and Forecast Research, Shares and Strategies | By Proficient Market Insights
  • Biosimilars Market: Rise in Number of Cancer Patients to Boost Market
  • Biotechnology and Pharmaceutical Services Outsourcing Market Size 2022 Analysis Report By Competitive Vendors in Top Regions and Countries, Production Types, Applications, Growth, Current Trends and Forecast to 2026
  • The Global Wearable Injectors Market Size is Expected to Reach $12.9 Billion By 2028, Rising at a Market Growth of 9.2% CAGR During the Forecast Period
  • Treprostinil Drugs Market – Insights on how Players Have Cemented Their Positions with Disruptive Technologies, Key Players are United Therapeutics, Novartis, and Teva Pharmaceutical Industries Ltd
  • Protect Pharmaceutical Corporation has Acquired Top Notch Software Development Company

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications